Baker Avenue Asset Management
HCAT icon

Baker Avenue Asset Management’s Health Catalyst HCAT Stock Holding History

Baker Avenue Asset Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40
Closed -$425 – 1682
2022
Q4 		$425 Buy
+40
New +$386 ﹤0.01% 1409

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Baker Avenue Asset Management's HCAT Position: Q1 2023 in Review

Baker Avenue Asset Management sold out of Health Catalyst (HCAT) in Q1 2023, closing a stake of 40 shares — an estimated $425 sold.

Baker Avenue Asset Management first reported a position in HCAT in Q4 2022 and held it in 1 quarter. The position peaked at $425 in Q4 2022. 161 funds tracked by Wall St. Rank hold HCAT as of Q1 2023.

  • Baker Avenue Asset Management reported no remaining Health Catalyst position as of Q1 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 40 Health Catalyst shares in Q1 2023, an estimated $425.
  • Baker Avenue Asset Management first reported a position in Health Catalyst in Q4 2022 and held it in 1 quarter.
  • Baker Avenue Asset Management's Health Catalyst position peaked at $425 in Q4 2022.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2023.

Based on Baker Avenue Asset Management's 13F filing for Q1 2023, filed 16 May 2023.